Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension

Coronavirus disease 2019 (COVID-19) is an infectious diseases caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, it is pandemic over the world. SARS-CoV-2 often causes a “cytokine storm” in people with COVID-19, causing inflammatory lung damage and pneumonia, which eventual...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Jong Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654461/
https://www.ncbi.nlm.nih.gov/pubmed/34916733
http://dx.doi.org/10.1016/j.mehy.2021.110739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654461/
https://www.ncbi.nlm.nih.gov/pubmed/34916733
http://dx.doi.org/10.1016/j.mehy.2021.110739

Ejemplares similares